Back to results

Anti notch3 antibody for cadasil treatment

The present invention relates to an anti-Notch 3 antibody therapy useful for treatment of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
More information (PDF)
Keywords: Neurology - Neurovascular -CADASIL - monoclonal antibody
Patent Application number: Denmark (NP) - 25 Sept. 2014 - PA201400547
Publications:
Brain. 2013 Jun;136(Pt 6):1830-45. doi: 10.1093/brain/awt092. Epub 2013 May 6.Ann Neurol. 2016 Mar;79(3):387-403. doi: 10.1002/ana.24573. Epub 2016 Feb 10.

Reference:

BIO11607-T1

    Business Developper
    contact
    Anne COCHI
    Business Development Manager
    Patent filling date: 18-09-2014
    Rare disease: Yes
    Second indication: No

    You might also be interested in